Jennifer Lin

Director, Early Development & In Process Analytics GSK

Seminars

Thursday 1st October 2026
Advancing Multi-Attribute Analytical Strategies to Accelerate mRNA Process Development & Product Quality Control
4:30 pm
  • Exploring how multi-attribute analytical approaches can consolidate identity, purity, integrity & dsRNA assessment into streamlined, data-rich workflows for mRNA development
  • Evaluating emerging technologies including sequencing-based and chromatographic assays to improve process understanding while reducing analytical complexity and turnaround time
  • Discussing how sensitive, high-throughput analytical platforms can support faster platform development, enhanced product quality & accelerated progression from discovery to IND-enabling studies
Jennifer Lin speaker for 5th mRNA Process Development & CMC Summit